SinoMab Announces Resignation of Executive Director and COO Fang Liang

Bulletin Express

Aug 18

SinoMab BioScience Limited has reported that Ms. Fang Liang resigned from her roles as executive director and chief operating officer, effective 18 August 2026. The company cites her decision to devote more time to personal endeavours.

According to the board, Ms. Liang expressed no disagreement with the directors, and there are no other matters requiring shareholder attention in connection with her departure. Following her resignation, she will not hold any position within the group.

The board expressed gratitude for Ms. Liang’s contributions and extended best wishes for her future pursuits. Dr. Shui On Leung remains the company’s executive director, chairman, and chief executive officer. Current board composition also includes three non-executive directors—Ms. Xiaosu Wang, Ms. Lei Xue and Dr. Jianmin Zhang—alongside five independent non-executive directors: Mr. George William Hunter Cautherley, Mr. Ping Cho Terence Hon, Dr. Chi Ming Lee, Ms. Chi Sau Giselle Lee and Mr. Nan Shen.

The announcement was issued in Hong Kong on 18 August 2026 by order of the board.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketb.com/news/1184290740"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184290740\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184290740?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184290740","market":"us","top_or_hot":-1,"title":"SinoMab Announces Resignation of Executive Director and COO Fang Liang","media":"Bulletin Express","content":"<p>SinoMab BioScience Limited has reported that Ms. Fang Liang resigned from her roles as executive director and chief operating officer, effective 18 August 2026. The company cites her decision to devote more time to personal endeavours.</p>\n<p>According to the board, Ms. Liang expressed no disagreement with the directors, and there are no other matters requiring shareholder attention in connection with her departure. Following her resignation, she will not hold any position within the group.</p>\n<p>The board expressed gratitude for Ms. Liang’s contributions and extended best wishes for her future pursuits. Dr. Shui On Leung remains the company’s executive director, chairman, and chief executive officer. Current board composition also includes three non-executive directors—Ms. Xiaosu Wang, Ms. Lei Xue and Dr. Jianmin Zhang—alongside five independent non-executive directors: Mr. George William Hunter Cautherley, Mr. Ping Cho Terence Hon, Dr. Chi Ming Lee, Ms. Chi Sau Giselle Lee and Mr. Nan Shen.</p>\n<p>The announcement was issued in Hong Kong on 18 August 2026 by order of the board.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SinoMab Announces Resignation of Executive Director and COO Fang Liang</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinoMab Announces Resignation of Executive Director and COO Fang Liang\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 18:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SinoMab BioScience Limited has reported that Ms. Fang Liang resigned from her roles as executive director and chief operating officer, effective 18 August 2026. The company cites her decision to devote more time to personal endeavours.</p>\n<p>According to the board, Ms. Liang expressed no disagreement with the directors, and there are no other matters requiring shareholder attention in connection with her departure. Following her resignation, she will not hold any position within the group.</p>\n<p>The board expressed gratitude for Ms. Liang’s contributions and extended best wishes for her future pursuits. Dr. Shui On Leung remains the company’s executive director, chairman, and chief executive officer. Current board composition also includes three non-executive directors—Ms. Xiaosu Wang, Ms. Lei Xue and Dr. Jianmin Zhang—alongside five independent non-executive directors: Mr. George William Hunter Cautherley, Mr. Ping Cho Terence Hon, Dr. Chi Ming Lee, Ms. Chi Sau Giselle Lee and Mr. Nan Shen.</p>\n<p>The announcement was issued in Hong Kong on 18 August 2026 by order of the board.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03681","symbol_name":"中国抗体-B","start_time":0,"source_url":"","article_id":"1184290740","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184290740","pubTimestamp":1787050030,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"SinoMab BioScience Limited has reported that Ms. Fang Liang resigned from her roles as executive director and chief operating officer, effective 18 August 2026. The company cites her decision to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03681":"中国抗体-B"},"translate_title":"SinoMab宣布执行董事兼首席运营官方亮辞职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03681":1},"content_text":"SinoMab BioScience Limited has reported that Ms. Fang Liang resigned from her roles as executive director and chief operating officer, effective 18 August 2026. The company cites her decision to devote more time to personal endeavours.\nAccording to the board, Ms. Liang expressed no disagreement with the directors, and there are no other matters requiring shareholder attention in connection with her departure. Following her resignation, she will not hold any position within the group.\nThe board expressed gratitude for Ms. Liang’s contributions and extended best wishes for her future pursuits. Dr. Shui On Leung remains the company’s executive director, chairman, and chief executive officer. Current board composition also includes three non-executive directors—Ms. Xiaosu Wang, Ms. Lei Xue and Dr. Jianmin Zhang—alongside five independent non-executive directors: Mr. George William Hunter Cautherley, Mr. Ping Cho Terence Hon, Dr. Chi Ming Lee, Ms. Chi Sau Giselle Lee and Mr. Nan Shen.\nThe announcement was issued in Hong Kong on 18 August 2026 by order of the board.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}